Normal Morphology, Physiological Changes, and Benign Breast Disease

  • Catherine N. Chinyama


Embryologically, the breast develops from the milk line and, in its simplest form, is viewed as a modified sweat gland. The structure and function of the breast is determined by several placental hormones, such as prolactin, estrogen, and progesterone. The latter two hormones influence physiological changes during life and to a greater extent the disease processes which affect the breast. Understanding normal breast development provides a foundation for understanding breast pathophysiology in general, and breast cancer in particular.


Needle Core Biopsy Benign Breast Disease Phyllode Tumor Epithelial Proliferation Radial Scar 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. •Chinyama CN. Benign breast diseases: radiology-pathology-risk assessment. Heidelberg: Springer; 2004.CrossRefGoogle Scholar
  2. •Chinyama CN, Davies JD. Mammary mucinous lesions: congeners, prevalence and important pathological associations. Histopathology. 1996;29:533–9.PubMedCrossRefGoogle Scholar
  3. •Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331:10–5.PubMedCrossRefGoogle Scholar
  4. •Hutter RVP et al. Is “fibrocystic disease” of the breast precancerous? Arch Pathol Lab Med. 1986;110:171–3.Google Scholar
  5. •Jacobs TW, Bryne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast biopsy specimens and the risk of breast cancer. N Eng J Med. 1999;340:430–6.CrossRefGoogle Scholar
  6. •Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer risk in women with sclerosing adenosis. Cancer. 1989;64:1977–83.PubMedCrossRefGoogle Scholar
  7. •Müller-Schimpfle M, Ohmenhäuser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145–9.PubMedGoogle Scholar
  8. •Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone; 1987.Google Scholar
  9. •Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartman WH. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst. 1987;61:1055–63.Google Scholar
  10. •Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78:258–66.PubMedCrossRefGoogle Scholar
  11. •Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibroadenoma. A review. Arch Pathol Lab Med. 1984;108:590–4.PubMedGoogle Scholar
  12. •Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol. 1999;23:1561.PubMedCrossRefGoogle Scholar
  13. •Sainsbury JR, Nicholson S, Needham GK, Wadehra V, Farndon JR. Natural history of the benign breast lump. Br J Surg. 1988;75:1080–2.PubMedCrossRefGoogle Scholar
  14. •Vogel PM, Georgiade NG, Fetter BF, et al. The correlation of histologic changes in the human breast with menstrual cycle. Am J Pathol. 1981;104:23–34.PubMedGoogle Scholar
  15. •Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol. 1986;17(2):185–91.PubMedCrossRefGoogle Scholar
  16. •Wellings SR, Alpers CE. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts. Hum Pathol. 1987;18:381–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer New York 2010

Authors and Affiliations

  1. 1.Department of PathologyPrincess Elizabeth Hospital, St. Martin’s, GuernseyChannel IslandsUK

Personalised recommendations